Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (24)
Iman Akhlaghipour, Amir Reza Bina, Mohammad Reza Abbaszadegan & Meysam Moghbeli. (2021) Methylation as a critical epigenetic process during tumor progressions among Iranian population: an overview. Genes and Environment 43:1.
Crossref
Crossref
Israa F. Mosa, Mokhtar Youssef, Maher Kamel, Osama F. Mosa & Yasser Helmy. (2019) Synergistic antioxidant capacity of CsNPs and CurNPs against cytotoxicity, genotoxicity and pro-inflammatory mediators induced by hydroxyapatite nanoparticles in male rats. Toxicology Research 8:6, pages 939-952.
Crossref
Crossref
Markus Christmann & Bernd Kaina. (2019) Epigenetic regulation of DNA repair genes and implications for tumor therapy. Mutation Research/Reviews in Mutation Research 780, pages 15-28.
Crossref
Crossref
Atefeh Razazan, Jessica Nicastro, Roderick Slavcev, Nastaran Barati, Atefeh Arab, Fatemeh Mosaffa, Mahmoud Reza Jaafari & Javad Behravan. (2019) Lambda bacteriophage nanoparticles displaying GP2, a HER2/neu derived peptide, induce prophylactic and therapeutic activities against TUBO tumor model in mice. Scientific Reports 9:1.
Crossref
Crossref
Nikola Jovanović, Tatjana Mitrović, Vladimir J. Cvetković, Svetlana Tošić, Jelena Vitorović, Slaviša Stamenković, Vesna Nikolov, Aleksandar Kostić, Nataša Vidović, Miljan Krstić, Tatjana Jevtović-Stoimenov & Dušica Pavlović. (2019) The Impact of MGMT Promoter Methylation and Temozolomide Treatment in Serbian Patients with Primary Glioblastoma. Medicina 55:2, pages 34.
Crossref
Crossref
Abhijeet Deshmukh, Mudra Binju, Frank Arfuso, Philip Newsholme & Arun Dharmarajan. (2017) Role of epigenetic modulation in cancer stem cell fate. The International Journal of Biochemistry & Cell Biology.
Crossref
Crossref
S. Trabelsi, N. Mama, M. Ladib, N. Karmeni, M. Haddaji Mastouri, M. Chourabi, M. Mokni, K. Tlili, H. Krifa, M. T. Yacoubi, A. Saad & D. H?mida Ben Brahim. (2015) MGMT methylation assessment in glioblastoma: MS-MLPA versus human methylation 450K beadchip array and immunohistochemistry. Clinical and Translational Oncology 18:4, pages 391-397.
Crossref
Crossref
A. Dullea & L. Marignol. (2015) MGMT testing allows for personalised therapy in the temozolomide era. Tumor Biology 37:1, pages 87-96.
Crossref
Crossref
Pooneh Mokarram, Soudabeh Kavousipour, Mostafa Moradi Sarabi, Golnosh Mehrabani, Mohammad Ali Fahmidehkar, Seyedeh Azra Shamsdin, Abbas Alipour & Mahvash Alizade Naini. (2015) MGMT-B Gene Promoter Hypermethylation in Patients with Inflammatory Bowel Disease - A Novel Finding. Asian Pacific Journal of Cancer Prevention 16:5, pages 1945-1952.
Crossref
Crossref
Uxia Saraiva-Esperón, Alvaro Ruibal & Michel Herranz. (2014) The contrasting epigenetic role of RUNX3 when compared with that of MGMT and TIMP3 in glioblastoma multiforme clinical outcomes. Journal of the Neurological Sciences 347:1-2, pages 325-331.
Crossref
Crossref
Dorota Jesionek-KupnickaMalgorzata SzybkaBeata MalachowskaWojciech FendlerPiotr PotemskiSylwester PiaskowskiDariusz JaskolskiWielislaw PapierzWieslaw SkowronskiWaldemar OchRadzislaw KordekIzabela Zawlik. (2014)
TP53
Promoter Methylation in Primary Glioblastoma: Relationship with
TP53
mRNA and Protein Expression and Mutation Status
. DNA and Cell Biology 33:4, pages 217-226.
Crossref
Crossref
Raheleh Jabini, Afshin Moradi, Sima Afsharnezhad, Hossein Ayatollahi, Javad Behravan, Hamid Reza Raziee & Fatemeh Mosaffa. (2014) Pathodiagnostic parameters and evaluation of O6? methyl guanine methyl transferase gene promoter methylation in meningiomas. Gene 538:2, pages 348-353.
Crossref
Crossref
Constantinos G. Broustas & Howard B. Lieberman. (2014) DNA Damage Response Genes and the Development of Cancer Metastasis. Radiation Research 181:2, pages 111-130.
Crossref
Crossref
Hee-Kwon ParkYoung-Cho KohSang Woo Song. (2014) The Clinico-Oncologic Outcomes of Elderly Patients with Glioblastoma after Surgical Resection Followed by Concomitant Chemo-Radiotherapy. Brain Tumor Research and Treatment 2:2, pages 69.
Crossref
Crossref
Andrew L. Lin, Jingxia Liu, John Evans, Eric C. Leuthardt, Keith M. Rich, Ralph G. Dacey, Joshua L. Dowling, Albert H. Kim, Gregory J. Zipfel, Robert L. Grubb, Jiayi Huang, Clifford G. Robinson, Joseph R. Simpson, Gerald P. Linette, Michael R. Chicoine & David D. Tran. (2014) Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. Neuro-Oncology 16:1, pages 123-130.
Crossref
Crossref
Yongzhi Wang & Tao Jiang. (2013) Understanding high grade glioma: Molecular mechanism, therapy and comprehensive management. Cancer Letters 331:2, pages 139-146.
Crossref
Crossref
Annette Bentsen Håvik, Petter Brandal, Hilde Honne, Hanne-Sofie Spenning Dahlback, David Scheie, Merete Hektoen, Torstein Ragnar Meling, Eirik Helseth, Sverre Heim, Ragnhild A Lothe & Guro Elisabeth Lind. (2012) MGMT promoter methylation in gliomas-assessment by pyrosequencing and quantitative methylation-specific PCR. Journal of Translational Medicine 10:1.
Crossref
Crossref
Emmanuèle Lechapt‐Zalcman, Guénaëlle Levallet, Audrey Emmanuelle Dugué, Anne Vital, Marie‐Danièle Diebold, Philippe Menei, Philippe Colin, Philippe Peruzzy, Evelyne Emery, Myriam Bernaudin, Françoise Chapon & Jean‐Sébastien Guillamo. (2012)
O
6
‐methylguanine‐DNA methyltransferase (MGMT) promoter methylation and low MGMT‐encoded protein expression as prognostic markers in glioblastoma patients treated with biodegradable carmustine wafer implants after initial surgery followed by radiotherapy with concomitant and adjuvant temozolomide
. Cancer 118:18, pages 4545-4554.
Crossref
Crossref
Adam J. Fleming & Susan N. Chi. (2012) Brain Tumors in Children. Current Problems in Pediatric and Adolescent Health Care 42:4, pages 80-103.
Crossref
Crossref
Atsushi Sato, Jun Sunayama, Ken-ichiro Matsuda, Shizuka Seino, Kaori Suzuki, Eriko Watanabe, Ken Tachibana, Arata Tomiyama, Takamasa Kayama & Chifumi Kitanaka. (2011) MEK-ERK Signaling Dictates DNA-Repair Gene MGMT Expression and Temozolomide Resistance of Stem-Like Glioblastoma Cells via the MDM2-p53 Axis. Stem Cells 29:12, pages 1942-1951.
Crossref
Crossref
Hyun-Cheol Kang, Chae-Yong Kim, Jung Ho Han, Ghee Young Choe, Jae Hyoung Kim, Jee Hyun Kim & In Ah Kim. (2010) Pseudoprogression in patients with malignant gliomas treated with concurrent temozolomide and radiotherapy: potential role of p53. Journal of Neuro-Oncology 102:1, pages 157-162.
Crossref
Crossref
C. Lahtz & G. P. Pfeifer. (2011) Epigenetic changes of DNA repair genes in cancer. Journal of Molecular Cell Biology 3:1, pages 51-58.
Crossref
Crossref
Marziyeh Lotfi, Sima Afsharnezhad, Hamid Reza Raziee, Kamran Ghaffarzadegan, Samaneh Sharif, Jamal Shamsara, Sara Lary & Javad Behravan. (2018) Immunohistochemical Assessment of MGMT Expression and p53 Mutation in Glioblastoma Multiforme. Tumori Journal 97:1, pages 104-108.
Crossref
Crossref
Prerana Jha, Vaishali Suri, Ayushi Jain, Mehar Chand Sharma, Pankaj Pathak, Pankaj Jha, Arti Srivastava, Ashish Suri, Deepak Gupta, Kunzang Chosdol, Parthoprasad Chattopadhyay & Chitra Sarkar. (2010) O 6-Methylguanine DNA Methyltransferase Gene Promoter Methylation Status in Gliomas and Its Correlation With Other Molecular Alterations: First Indian Report With Review of Challenges for Use in Customized Treatment. Neurosurgery 67:6, pages 1681-1691.
Crossref
Crossref